Has Thomas Stuckey received payments from drug or device companies?

Yes. Drug and device makers reported $36,489 in general payments to Thomas Stuckey across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Stuckey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Stuckey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Stuckey

Interventional Cardiology · Greensboro, NCNPI 1376593731

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $26,250 of the $36,489 with a category attached, or 71.9%. Chiesi USA, Inc. accounts for 83.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $14,636 and has fallen 86.5% since, to $1,975 in 2025.

$36,489in general payments, 2019–2025

Across 117 payments — averaging $311.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Chiesi USA, Inc.$30K
Medtronic$2K
Actelion Pharmaceuticals, Ltd$1K
Abiomed$880
Cvrx, Inc.$786
Abbott$551
plus $1K from 9 others

$893,369in research payments, 2019–2025

Across 47 payments — averaging $19,008 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$723K
Janssen Research & Development, LLC$96K
Amgen$40K
Merck$20K
Regeneron$14K

What the payments were for

Speaking & faculty fees$26,25072%
Travel & lodging$6,34717%
Food & beverage$3,86211%
Education$300%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Chiesi USA, Inc.	47	$30,281
Medtronic	13	$1,850
Actelion Pharmaceuticals, Ltd	4	$1,022
Abiomed	2	$880
Cvrx, Inc.	20	$786
Abbott	7	$551
Amgen	7	$251
Boston Scientific	1	$171
Heartflow, Inc.	5	$125
Teleflex LLC	1	$124
Impulse Dynamics (USA) Inc.	1	$115
Livanova USA, Inc.	6	$112
Novartis	1	$97
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$96
Edwards Lifesciences	1	$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,489 in reported general payments places this provider in the 80th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina →

Other interventional cardiology in Greensboro

George AdamsGarner$4.1M
Paul MahoneyGreenville$1.7M
Ravish SacharRaleigh$1.6M
Patrick SimpsonPinehurst$579K
Ronald UszenskiMooresville$495K
Oluseun AlliCharlotte$485K
Matthew CavenderChapel Hill$453K
Steven FilbyPinehurst$442K
Naveed RajperStatesville$223K
Siddhartha RaoCary$223K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →